Protective role of SIRT1 (rs3758391 T > C) polymorphism against T2DM and its complications: Influence on GPx activity
- PMID: 39474345
- PMCID: PMC11518819
- DOI: 10.1002/hsr2.70106
Protective role of SIRT1 (rs3758391 T > C) polymorphism against T2DM and its complications: Influence on GPx activity
Abstract
Background and aims: Sirtuin-1 (SIRT1) has antidiabetic effects through the regulation of insulin secretion and modulation of inflammation. The SIRT1 rs3758391 gene polymorphism affects the level of SIRT1. The current study aimed to investigate the possible influence of SIRT1 gene variants in relation to oxidative stress parameters on the susceptibility to type 2 diabetes mellitus (T2DM) and its microvascular complications.
Methods: In this case-control study 398 individuals including 300 patients with T2DM (100 T2DM without complication, 100 diabetic neuropathy patients and 100 patients with diabetic retinopathy) and 98 healthy subjects were studied for SIRT1 rs3758391 T > C variants. Also, the glutathione peroxidase (GPx) activity and the levels of glutathione (GSH), malondialdehyde (MDA), total antioxidant capacity (TAC), and total oxidative status (TOS) were determined by colorimetric methods. SIRT1 genotypes were detected using the polymerase chain reaction-restriction fragment length polymorphism method.
Results: The C allele of SIRT1 reduced the risk of T2DM, diabetic neuropathy and diabetic retinopathy. Significantly lower levels of GSH, GPx, and TAC were found in diabetic patients compared to control group. However, the level of MDA was significantly higher in patients compared to healthy individuals. Considering all individuals, the GPx activity increased in the presence of the SIRT1 CC, and TC genotypes compared to the TT genotype. Among all studied individuals the activity of GPx was significantly higher in normal body mass index (BMI) subjects than overweight, and obese individuals. However, among overweight and obese diabetic, diabetic retinopathy and diabetic neuropathy patients the mean level of TOS was significantly higher compared to patients with normal BMI.
Conclusions: Our findings suggest a protective role for SIRT1 C allele against T2DM and diabetic neuropathy and diabetic retinopathy. We found in the presence of this allele the GPx activity increased. Also, we detected an enhanced oxidative stress level among overweight and obese patients with diabetes and its complications that could be involved in the pathogenesis of the disease.
Keywords: SIRT1 gene variants; T2DM; antioxidants; diabetic neuropathy; diabetic retinopathy.
© 2024 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Conflict of interest statement
Zohreh Rahimi is an Editorial Board member of Health Science Reports and a coauthor of this article. To minimize bias, they were excluded from all editorial decision‐making related to the acceptance of this article for publication. The remaining authors declare no conflict of interest.
Figures
Similar articles
-
Assessing the possible association between MTHFR (rs1801133) and GPx-1 (rs1050450) polymorphisms with the risk of type 2 diabetes, diabetic neuropathy, and diabetic retinopathy.Mol Biol Rep. 2024 Apr 29;51(1):583. doi: 10.1007/s11033-024-09519-0. Mol Biol Rep. 2024. PMID: 38683407
-
Oxidative stress parameters and keap 1 variants in T2DM: Association with T2DM, diabetic neuropathy, diabetic retinopathy, and obesity.J Clin Lab Anal. 2022 Jan;36(1):e24163. doi: 10.1002/jcla.24163. Epub 2021 Dec 3. J Clin Lab Anal. 2022. PMID: 34861061 Free PMC article.
-
The influence of LPL S447X variants and obesity on lipid profile, oxidative stress, and the risk of T2DM: A case-control study.Health Sci Rep. 2023 Jan 2;6(1):e1031. doi: 10.1002/hsr2.1031. eCollection 2023 Jan. Health Sci Rep. 2023. PMID: 36605456 Free PMC article.
-
Common Genetic Variants in SIRT1 Gene Promoter and Type 2 Diabetes Mellitus in Saudi Arabia.Clin Lab. 2024 Feb 1;70(2). doi: 10.7754/Clin.Lab.2023.230804. Clin Lab. 2024. PMID: 38345973
-
SIRT1: a promising therapeutic target in type 2 diabetes mellitus.Arch Physiol Biochem. 2024 Feb;130(1):13-28. doi: 10.1080/13813455.2021.1956976. Epub 2021 Aug 11. Arch Physiol Biochem. 2024. PMID: 34379994 Review.
References
-
- Sher EK, Džidić‐Krivić A, Karahmet A, et al. Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy—a review. Diab Metabol Synd. 2023;17(11):102901. - PubMed
-
- Karbasforooshan H, Karimi G. The role of SIRT1 in diabetic retinopathy. Biomed Pharmacother Biomed Pharmacother. 2018;97:190‐194. - PubMed
LinkOut - more resources
Full Text Sources